NeuShen Therapeutics
Business Services · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
a1023 room no.1077 Zhangheng Rd, Shangha...Website
www.neushen.comRevenue
$9.5 MillionIndustry
About NeuShen Therapeutics
NeuShen Therapeutics Org Chart
Is NeuShen Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
NeuShen Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once NeuShen Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at NeuShen Therapeutics
Product Launch: Get notified when NeuShen Therapeutics launches new products
Check out if NeuShen Therapeutics is spiking on competitors!
Check if NeuShen Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if NeuShen Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on NeuShen Therapeutics recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined NeuShen Therapeutics as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
NeuShen Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
NeuShen Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NeuShen Therapeutics.
NeuShen Therapeutics financials insights
Gather financial insights about NeuShen Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Other Financing Round
$20M
Series B
$80M
NeuShen Therapeutics Tech Stack
A closer look at the technologies used by NeuShen Therapeutics
Most Recent Scoops
NeuShen Therapeutics News & Media
NeuShen Therapeutics Initiates First-in-Human Trial of NS-136, a Novel Selective M4 Receptor Positive Allosteric Modulator for the Treatment of Schizophrenia
SHANGHAI and LEXINGTON, Mass. , May 8, 2024 /PRNewswire/ -- NeuShen Therapeutics (the "Company"), a clinical-stage global biotechnology company dedicated to pioneering treatments for neurological and psychiatric disorders, today announced the dosing of the first healthy volunteer in Australia in the Phase I first-in-human clinical trial of NS-136, a novel selective M4 receptor positive allosteric modulator (M4 PAM) designed for the treatment of schizophrenia and other conditions associated withNeuShen Therapeutics Closes Approx. $20M Pre-A Financing
NeuShen Therapeutics, a Shanghai, China and Boston, MA-based biotechnology company focusing on developing treatments for central nervous system (CNS) disorders, raised approx. $20M in Pre-Series A funding. The round was led by Lapam Capital. The company intends to use the funds to expand the team and catalyze in-house CNS drug discovery in both the US and China. Led […] The post NeuShen Therapeutics Closes Approx. $20M Pre-A Financing appeared first on FinSMEs.
Top Business Services Companies
Frequently Asked Questions Regarding NeuShen Therapeutics
Founded in 2021, NeuShen Therapeutics is a biotechnology company with a focus on neurological and psychiatric disorders. The company is headquartered in Shanghai, China.... Read More